ブリグチニブ
↑ “KEGG DRUG: ブリグチニブ”. www.genome.jp. 2021年3月26日閲覧。
1 2 “Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase”. Journal of Medicinal Chemistry 59 (10): 4948–64. (May 2016). doi:10.1021/acs.jmedchem.6b00306. PMID 27144831.
↑ “Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer”. Nature Communications 8: 14768. (March 2017). Bibcode: 2017NatCo...814768U. doi:10.1038/ncomms14768. PMC 5355811. PMID 28287083. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355811/.